(Q46095548)
Statements
Disrupted serotonergic and sympathoadrenal systems in patients with chronic heart failure may serve as new therapeutic targets and novel biomarkers to assess severity, progression and response to treatment (English)
András Palotás
Marat A Mukhamedyarov
Razina R Nigmatullina
Roen K Jourjikiya
Vladimir S Kudrin